The interplay between microRNAs and histone deacetylases in neurological diseases

Neurochemistry International

Volumn 77, Issue , 2014, Pages 33-39

  Bourassa, Megan W ^a   Ratan, Rajiv R ^a,b  

^a Burke Cornell Medical Research Institute   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Histone deacetylase; MicroRNA; Neurodegeneration; Neurological conditions

Indexed keywords

HISTONE DEACETYLASE; MICRORNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HISTONE ACETYLATION; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; REVIEW; ENZYMOLOGY; GENETICS; METABOLISM;

HISTONE DEACETYLASES; HUMANS; MICRORNAS; NERVOUS SYSTEM DISEASES;

EID: 84907476397     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.03.012     Document Type: Review

References (52)

1. A. Abbott Dementia: a problem for our age Nature 475 2011 S2 S4
2. J.E. Babiarz, J.G. Ruby, Y. Wang, D.P. Bartel, and R. Blelloch Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs Genes Dev. 22 2008 2773 2785
3. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
4. G. Bruneteau, T. Simonet, S. Bauché, N. Mandjee, E. Malfatti, E. Girard, M.-L. Tanguy, A. Behin, F. Khiami, and E. Sariali Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression Brain 136 2013 2359 2368
5. D.-M. Chuang, Y. Leng, Z. Marinova, H.-J. Kim, and C.-T. Chiu Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci. 32 2009 591 601
6. H.Y. Cohen, C. Miller, K.J. Bitterman, N.R. Wall, B. Hekking, B. Kessler, K.T. Howitz, M. Gorospe, R. de Cabo, and D.A. Sinclair Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase Science 305 2004 390 392
7. T.J. Cohen, D.S. Waddell, T. Barrientos, Z. Lu, G. Feng, G.A. Cox, S.C. Bodine, and T.-P. Yao The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming J. Biol. Chem. 282 2007 33752 33759
8. C. Conaco, S. Otto, J.-J. Han, and G. Mandel Reciprocal actions of REST and a microRNA promote neuronal identity Proc. Natl. Acad. Sci. U.S.A. 103 2006 2422 2427
9. G. Donmez, D. Wang, D.E. Cohen, and L. Guarente SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10 Cell 142 2010 320 332
10. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N.W. Kowall, R.R. Ratan, and R. Luthi-Carter Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J. Neurosci. 23 2003 9418 9427
11. J. Gao, W.-Y. Wang, Y.-W. Mao, J. Gräff, J.-S. Guan, L. Pan, G. Mak, D. Kim, S.C. Su, and L.-H. Tsai A novel pathway regulates memory and plasticity via SIRT1 and miR-134 Nature 466 2010 1105 1109
12. E.F. Goodall, P.R. Heath, O. Bandmann, J. Kirby, and P.J. Shaw Neuronal dark matter: the emerging role of microRNAs in neurodegeneration Front. Cell. Neurosci. 7 2013 1 16
13. S.S. Hébert, K. Horré, L. Nicolaï, A.S. Papadopoulou, W. Mandemakers, A.N. Silahtaroglu, S. Kauppinen, A. Delacourte, and B. De Strooper Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression Proc. Natl. Acad. Sci. 105 2008 6415 6420
14. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, and P.A. Lowden Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. 100 2003 2041 2046
15. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, and L.-L. Zhang Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
16. Y. Huang, A.Y. Chuang, and E.A. Ratovitski Phospho-ΔNp63alpha/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure Cell Cycle 10 2011 3938 3947
17. J.G. Hunsberger, E.B. Fessler, Z. Wang, A.G. Elkahloun, and D.-M. Chuang Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia Am. J. Transl. Res. 4 2012 316 332
18. K. Jeyaseelan, K.Y. Lim, and A. Armugam MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion Stroke 39 2008 959 966
19. R. Johnson, C. Zuccato, N.D. Belyaev, D.J. Guest, E. Cattaneo, and N.J. Buckley A microRNA-based gene dysregulation pathway in Huntington's disease Neurobiol. Dis. 29 2008 438 445
20. A. Jovicic, J.F.Z. Jolissaint, R. Moser, M.d.F.S. Santos, and R. Luthi-Carter MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific huntington, Äôs disease-related mechanisms PLoS One 8 2013 e54222
21. A. Krek, D. Grün, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, and M. Stoffel Combinatorial microRNA target predictions Nat. Genet. 37 2005 495 500
22. B. Langley, C. Brochier, and M.A. Rivieccio Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke Stroke 40 2009 2899 2905
23. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
24. B.P. Lewis, I.-H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
25. L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, and J.M. Johnson Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769 773
26. M.E. MacDonald, C.M. Ambrose, M.P. Duyao, R.H. Myers, C. Lin, L. Srinidhi, G. Barnes, S.A. Taylor, M. James, and N. Groot A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
27. S. Michán, Y. Li, M.M.-H. Chou, E. Parrella, H. Ge, J.M. Long, J.S. Allard, K. Lewis, M. Miller, and W. Xu SIRT1 is essential for normal cognitive function and synaptic plasticity J. Neurosci. 30 2010 9695 9707
28. M. Mielcarek, C.L. Benn, S.A. Franklin, D.L. Smith, B. Woodman, P.A. Marks, and G.P. Bates SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease PLoS One 6 2011 e27746
29. A.N. Packer, Y. Xing, S.Q. Harper, L. Jones, and B.L. Davidson The bifunctional microRNA miR-9/miR-9∗ regulates REST and CoREST and is downregulated in Huntington's disease J. Neurosci. 28 2008 14341 14346
30. W. Qin, T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, and J.T. Rodgers Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J. Biol. Chem. 281 2006 21745 21754
31. P.K. Rao, R.M. Kumar, M. Farkhondeh, S. Baskerville, and H.F. Lodish Myogenic factors that regulate expression of muscle-specific microRNAs Proc. Natl. Acad. Sci. 103 2006 8721 8726
32. A.A. Saraiya, and C.C. Wang SnoRNA, a novel precursor of microRNA in Giardia lamblia PLoS Pathog. 4 2008 e1000224
33. A.M. Schaefer, J.R. Sanes, and J.W. Lichtman A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis J. Comp. Neurol. 490 2005 209 219
34. N. Schonrock, and J. Götz Decoding the non-coding RNAs in Alzheimer's disease Cell. Mol. Life Sci. 69 2012 3543 3559
35. N. Schonrock, Y.D. Ke, D. Humphreys, M. Staufenbiel, L.M. Ittner, T. Preiss, and J. Götz Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta PLoS One 5 2010 e11070
36. G.K. Scott, M.D. Mattie, C.E. Berger, S.C. Benz, and C.C. Benz Rapid alteration of microRNA levels by histone deacetylase inhibition Cancer Res. 66 2006 1277 1281
37. S.F. Sleiman, M. Basso, L. Mahishi, A.P. Kozikowski, M.E. Donohoe, B. Langley, and R.R. Ratan Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions Expert Opin. Investig. Drugs 18 2009 573 584
38. J.S. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, B.L. Apostol, A. Kazantsev, E. Schmidt, Y.-Z. Zhu, and M. Greenwald Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743
39. H. Tang, P. Macpherson, M. Marvin, E. Meadows, W.H. Klein, X.-J. Yang, and D. Goldman A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression Mol. Biol. Cell 20 2009 1120 1131
40. D. Tardito, A. Mallei, and M. Popoli Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs Expert Opin. Investig. Drugs 22 2013 217 233
41. E.A. Thomas, G. Coppola, P.A. Desplats, B. Tang, E. Soragni, R. Burnett, F. Gao, K.M. Fitzgerald, J.F. Borok, and D. Herman The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice Proc. Natl. Acad. Sci. 105 2008 15564 15569
42. J.S. Valentine, P.A. Doucette, and S. Zittin Potter Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis Annu. Rev. Biochem. 74 2005 563 593
43. W.-X. Wang, B.W. Rajeev, A.J. Stromberg, N. Ren, G. Tang, Q. Huang, I. Rigoutsos, and P.T. Nelson The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1 J. Neurosci. 28 2008 1213 1223
44. A.H. Williams, G. Valdez, V. Moresi, X. Qi, J. McAnally, J.L. Elliott, R. Bassel-Duby, J.R. Sanes, and E.N. Olson MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice Science 326 2009 1549 1554
45. G. Wohlfart Collateral regeneration from residual motor nerve fibers in amyotrophic lateral sclerosis Neurology 7 1957 124-124
46. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and D. Sinclair Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689
47. M. Yamakuchi, M. Ferlito, and C.J. Lowenstein MiR-34a repression of SIRT1 regulates apoptosis Proc. Natl. Acad. Sci. 105 2008 13421 13426
48. L.A. Yates, C.J. Norbury, and R.J. Gilbert The long and short of MicroRNA Cell 153 2013 516 519
49. Y.-E. Yoo, and C.-P. Ko Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis Exp. Neurol. 231 2011 147 159
50. Y.N. Zhao, W.F. Li, F. Li, Z. Zhang, Y.D. Dai, A.L. Xu, C. Qi, J.M. Gao, and J. Gao Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway Biochem. Biophys. Res. Commun. 2013
51. R. Zhou, P. Yuan, Y. Wang, J.G. Hunsberger, A. Elkahloun, Y. Wei, P. Damschroder-Williams, J. Du, G. Chen, and H.K. Manji Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers Neuropsychopharmacology 34 2009 1395 1405
52. A. Zovoilis, H.Y. Agbemenyah, R.C. Agis-Balboa, R.M. Stilling, D. Edbauer, P. Rao, L. Farinelli, I. Delalle, A. Schmitt, and P. Falkai MicroRNA-34c is a novel target to treat dementias EMBO J. 30 2011 4299 4308